Estrogen replacement therapy and cardioprotection: mechanisms and controversies
Open Access
- 1 March 2002
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 35 (3) , 271-276
Abstract
Epidemiological and case-controlled studies suggest that estrogen replacement therapy might be beneficial in terms of primary prevention of coronary heart disease (CHD). This beneficial effect of estrogens was initially considered to be due to the reduction of low density lipoproteins (LDL) and to increases in high density lipoproteins (HDL). Recent studies have shown that estrogens protect against oxidative stress and decrease LDL oxidation. Estrogens have direct effects on the arterial tissue and modulate vascular reactivity through nitric oxide and prostaglandin synthesis. While many of the effects of estrogen on vascular tissue are believed to be mediated by estrogen receptors alpha and ß, there is evidence for `immediate non-genomic' effects. The role of HDL in interacting with 17ß-estradiol including its esterification and transfer of esterified estrogens to LDL is beginning to be elucidated. Despite the suggested positive effects of estrogens, two recent placebo-controlled clinical trials in women with CHD did not detect any beneficial effects on overall coronary events with estrogen therapy. In fact, there was an increase in CHD events in some women. Mutations in thrombogenic genes (factor V Leiden, prothrombin mutation, etc.) in a subset of women may play a role in this unexpected finding. Thus, the cardioprotective effect of estrogens appears to be more complicated than originally thought and requires more research.Keywords
This publication has 52 references indexed in Scilit:
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal WomenNew England Journal of Medicine, 1997
- Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancerBritish Journal of Surgery, 1996
- Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimensAtherosclerosis, 1996
- Hormone replacement therapy, hormone levels, and lipoprotein cholesterol concentrations in elderly womenAmerican Journal of Obstetrics and Gynecology, 1996
- Postmenopausal estrogens and breast cancerJournal of the Society for Gynecologic Investigation, 1996
- Effects of the antiestrogen tamoxiten on low-density lipoprotein concentrations and oxidation in postmenopausal womenThe American Journal of Cardiology, 1995
- Up‐regulation of nitric oxide synthase by estradiol in human aorticendothelial cellsFEBS Letters, 1995
- Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidencePreventive Medicine, 1991